Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. is a small business in Purchase, NY registered on SAM.gov to bid on federal contracts. It has won 9 small business R&D awards worth $9.4 million through the SBIR and STTR programs since 2016, according to SBIR.gov.
- UEI
- NUNHAKQ7MS86
- CAGE code
- 5CQK3
- SAM.gov registration
- Active
Registration details
From SAM.gov's monthly public file dated Oct 5, 2026. If the business has updated its registration since, SAM.gov shows the newer details.
| Legal business name | Cognition Therapeutics, Inc. |
|---|---|
| Unique Entity ID (UEI) | NUNHAKQ7MS86 |
| CAGE code | 5CQK3 |
| Location | Purchase, NY |
| SAM.gov registration | Active through Mar 11, 2027 |
| Business started | 2007 |
| Primary NAICS code | 541714: Research and Development in Biotechnology (except Nanobiotechnology) |
| Website | www.cogrx.com |
Certifications and business types
SAM.gov's public file from Oct 5, 2026 lists no SBA certification (8(a), HUBZone or WOSB) for Cognition Therapeutics, Inc.. The file sometimes leaves a certification out, and a newer one won't be in it yet: SBA's certification search and the firm's SAM.gov entry have the current list. SBA certifications let a business compete for set-aside contracts. See set-aside contracts explained.
SBIR and STTR awards
Cognition Therapeutics, Inc. has won 9 small business R&D awards worth $9.4 million through the SBIR and STTR programs since 2016, 5 of them Phase II and 2 STTR. Funded by NIH.
| Awarded | Agency | Project | Amount |
|---|---|---|---|
| May 1, 2021 | NIH | SBIR Phase II Human AME study of CT1812, a small molecule in phase 2 clinical trials for the treatment of… | $1.6 million |
| Sep 1, 2019 | NIH | SBIR Phase II Mechanism of action of oligomer-displacing Alzheimer investigation drug, CT1812:Receptor… | $1.4 million |
| Sep 30, 2018 | NIH | SBIR Phase I Mechanism of action of oligomer-displacing Alzheimer investigation drug, CT1812:Receptor… | $360,119 |
| Sep 15, 2018 | NIH | STTR Phase II Optimization of sigma-2 receptor modulators for the treatment of cognitive dysfunction | $2.1 million |
| Jun 15, 2018 | NIH | SBIR Phase II Structural variants of Abeta oligomer displacing small molecules | $1.5 million |
| Sep 15, 2017 | NIH | SBIR Phase I Structural variants of Abeta oligomer displacing small molecules | $224,147 |
| Apr 1, 2017 | NIH | SBIR Phase II Target Engagement Biomarkers for Alzheimer's Therapeutics | $1.7 million |
| Sep 30, 2016 | NIH | SBIR Phase I Target Engagement Biomarkers for Alzheimer's Therapeutics | $222,004 |
Showing the newest 8. Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.
Federal contract history
USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.
NAICS codes Cognition Therapeutics, Inc. is small under
On its SAM.gov registration, Cognition Therapeutics, Inc. meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.
Open contracts in Cognition Therapeutics, Inc.'s NAICS codes
39 open federal opportunities on SAM.gov use one of Cognition Therapeutics, Inc.'s NAICS codes and are open to it: no set-aside, or, in the codes it is registered small under, a small business set-aside or one for a certification it holds. Here are a few, those in its primary code first (none of these are in New York right now), then the soonest due.
- UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Event or sign-up Oct 14, 2026
- Protein ENGineering (PENG)
✦ DARPA's Defense Sciences Office wants teams to build a platform that can edit existing (endogenous) proteins inside living cells, without permanently changing DNA. It is a…
Due in 8 daysOct 19, 2026
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
✦ NIH (NIDA) is running a sources sought notice, not a solicitation, to find companies that can run, consolidate or recompete NIH biorepositories for FY 2028.
Due in 9 daysOct 20, 2026
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
✦ NIH (through NIDA) is asking small businesses whether they can run one or more NIH biorepositories (sample banks) for FY 2028, including the NIDA Center for Genetic Studies and…
Due in 9 daysOct 20, 2026
- NAWCWD Broad Agency Announcement
Due in 19 daysOct 30, 2026
Similar small businesses
Other small businesses of a similar size with the same primary NAICS code (541714) that have won federal contracts in New York:
- Glyphic Biotechnologies, Inc., New York, NY
- Ifyber, LLC, Ithaca, NY
- Stellar Notch, LLC, New York, NY
- Ampersand Biosciences LLC, Lake Clear, NY
- Epibone, Inc., New York, NY
- Jan Biotech, Inc., Ithaca, NY
Frequently asked questions
What is Cognition Therapeutics, Inc.'s CAGE code?
Cognition Therapeutics, Inc.'s CAGE code is 5CQK3. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.
What is Cognition Therapeutics, Inc.'s UEI?
Cognition Therapeutics, Inc.'s Unique Entity ID (UEI) is NUNHAKQ7MS86. SAM.gov assigns the UEI, and it identifies the business across the federal government.
Is Cognition Therapeutics, Inc.'s SAM.gov registration active?
Yes, as of SAM.gov's public data from Oct 5, 2026, Cognition Therapeutics, Inc.'s registration is active through Mar 11, 2027. Registrations are renewed every year.
Is Cognition Therapeutics, Inc. a small business?
Cognition Therapeutics, Inc. is registered on SAM.gov as small under 2 NAICS codes, including its primary code, 541714. Size is set per NAICS code, so a business can be small for some contracts and not others.
Keep going
- Look up another business's CAGE code or UEI
- Check a SAM.gov registration's status
- How to become a government subcontractor
Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To report a mistake on this page, or to ask us to remove it, email hello@fedready.us with the page address; we reply within 2 business days. For a removal, write from an address at the company.